Jane Street’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12M Sell
128,490
-208,267
-62% -$19.6M ﹤0.01% 2651
2026
Q1
$29.9M Sell
336,757
-1,024,464
-75% -$105M ﹤0.01% 1448
2025
Q4
$130M Buy
1,361,221
+1,164,203
+591% +$117M 0.02% 475
2025
Q3
$19.4M Buy
+197,018
New +$21.1M ﹤0.01% 1689
2025
Q2
Sell
-78,082
Closed -$7.89M 9665
2025
Q1
$7.11M Sell
78,082
-55,520
-42% -$6.22M ﹤0.01% 2416
2024
Q4
$15.2M Buy
133,602
+92,472
+225% +$10.6M ﹤0.01% 1497
2024
Q3
$4.89M Sell
41,130
-16,053
-28% -$1.48M ﹤0.01% 2900
2024
Q2
$4.6M Sell
57,183
-37,275
-39% -$3.41M ﹤0.01% 3094
2024
Q1
$8.71M Sell
94,458
-15,502
-14% -$1.49M ﹤0.01% 1959
2023
Q4
$11.6M Buy
109,960
+65,882
+149% +$6.64M ﹤0.01% 1786
2023
Q3
$4.79M Sell
44,078
-26,792
-38% -$2.96M ﹤0.01% 2667
2023
Q2
$7.65M Sell
70,870
-7,751
-10% -$872K ﹤0.01% 2209
2023
Q1
$9.79M Buy
78,621
+12,608
+19% +$1.73M ﹤0.01% 1664
2022
Q4
$9.92M Buy
66,013
+39,878
+153% +$6.14M ﹤0.01% 1633
2022
Q3
$3.52M Sell
26,135
-79,926
-75% -$12.2M ﹤0.01% 3200
2022
Q2
$15.8M Sell
106,061
-18,279
-15% -$2.79M 0.01% 1314
2022
Q1
$21.2M Sell
124,340
-124,719
-50% -$21M 0.01% 1217
2021
Q4
$64.2M Buy
249,059
+127,661
+105% +$35M 0.02% 543
2021
Q3
$33.1M Buy
121,398
+54,878
+82% +$17.4M 0.01% 787
2021
Q2
$14.9M Sell
66,520
-17,289
-21% -$3.26M 0.01% 1332
2021
Q1
$9.15M Sell
83,809
-196,367
-70% -$20.9M ﹤0.01% 1639
2020
Q4
$22.8M Buy
280,176
+138,786
+98% +$13.6M 0.01% 790
2020
Q3
$9.7M Buy
141,390
+93,827
+197% +$6.73M 0.01% 1237
2020
Q2
$3.19M Buy
47,563
+34,314
+259% +$1.71M ﹤0.01% 2423
2020
Q1
$774K Buy
+13,249
New +$516K ﹤0.01% 3099

Other funds holding BNTX

Jane Street's BNTX Position: Q2 2026 in Review

Jane Street reduced its BioNTech (BNTX) stake by 62% in Q2 2026, selling an estimated $19.6M and leaving 128,490 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

Jane Street first reported a position in BNTX in Q1 2020 and has held it in 25 quarters since. The position peaked at $130M in Q4 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Jane Street held 128,490 shares of BioNTech worth $12M as of Q2 2026.
  • Jane Street sold 208,267 BioNTech shares in Q2 2026, an estimated $19.6M.
  • BioNTech made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #2651 holding.
  • Jane Street first reported a position in BioNTech in Q1 2020 and has held it in 25 quarters since.
  • Jane Street's BioNTech position peaked at $130M in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.